Binfeng Lu

9PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer geneticsTumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 06, 2026
mTORC1 suppression by Trp53 mutation drives resistance to immune checkpoint blockade.

|Apr 17, 2026
Dedifferentiation-driven oncogenic stemness promotes tumor-sustaining adaptability in the intestinal epithelium.

|Jul 24, 2025
Specific inhibitor to KRASG12C induces tumor-specific immunity and synergizes with oncolytic virus for enhanced cancer immunotherapy.

Zhi Zhu, Hongqi Chen, Chao Feng

|Feb 16, 2024
Measuring the composition of the tumor microenvironment with transcriptome analysis: past, present and future.

Han Zhang, Xinghua Lu, Binfeng Lu

|Jan 04, 2024
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy.

Zhangyi Luo, Yixian Huang, Neelu Batra

|Aug 23, 2023
Amphiregulin couples IL1RL1+ regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity.

Runzi Sun, Hongyu Zhao, David Shihong Gao

Pageof 2

Frequent Collaborators

4 joint publications

Song Li

3 joint publications

Da Yang

3 joint publications

Yuang Chen

2 joint publications

Min Zhang